You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2024

~ Buy the GIVLAARI (givosiran sodium) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR GIVLAARI

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for GIVLAARI

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03338816 ↗	ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)	Completed	Alnylam Pharmaceuticals	Phase 3	2017-11-16	The purpose of this study is to evaluate the effect of subcutaneous givosiran (ALN-AS1), compared to placebo, on the rate of porphyria attacks in patients with Acute Hepatic Porphyrias (AHP).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for GIVLAARI

Condition Name

Chart
Table

Condition Name for GIVLAARI
Intervention	Trials
Variegate Porphyria (VP)	1
Acute Hepatic Porphyria	1
Acute Intermittent Porphyria	1
Acute Porphyria	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for GIVLAARI
Intervention	Trials
Porphyrias	1
Porphyria, Variegate	1
Porphyria, Erythropoietic	1
Porphyria, Acute Intermittent	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for GIVLAARI

Trials by Country

Map
Table

Trials by Country for GIVLAARI
Location	Trials
United States	10
Australia	2
Canada	1
France	1
Japan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for GIVLAARI
Location	Trials
Washington	1
Utah	1
Texas	1
Pennsylvania	1
North Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for GIVLAARI

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for GIVLAARI
Clinical Trial Phase	Trials
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for GIVLAARI
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GIVLAARI

Sponsor Name

Chart
Table

Sponsor Name for GIVLAARI
Sponsor	Trials
Alnylam Pharmaceuticals	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for GIVLAARI
Sponsor	Trials
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.